Hypertension
The Prevalence and Treatment of Hypertension in Long-Term Care Settings: Implications for Quality of Care of the Frail Elderly The Prevalence and Treatment of Hypertension in Long-Term Care Settings: Implications for Quality of Care of the Frail Elderly Colleen J. Maxwell, PhD, David B. Hogan, MD, FACP, FRCPC, and John P. Hirdes, PhD This article reviews findings regarding the prevalence of hypertension and correlates of treatment among older nursing home residents and presents comparable ...
Treatment of Older Persons After Myocardial Infarction Treatment of Older Persons After Myocardial Infarction Wilbert S. Aronow, MD, CMD Coronary risk factors should be modified in older persons after myocardial infarction (MI). An analysis of 55 randomized controlled trials including 53,268 persons showed that beta blockers significantly reduced mortality by 19% after MI.43 Metoprolol,44 timolol,45,46 and propranolol47 caused a greater decrease in mortality after MI in older persons than in...
The early diagnosis and treatment of Alzheimer?s disease brings benefit to the patient, his or her family, and the caregivers. Slowing or delaying the progression of disease reduces morbidity, improves functional independence, and decreases overall expense. The interface between cardiovascular health and dementia affords even greater opportunity to impact the management of Alzheimer?s disease by recognizing and treating other comorbidities. As we further understand mild cognitive impairment, there may be additional opportunities to intervene even earlier. The authors present the case of a woman with short-term memory loss. (Annals of Long-Term Care: Clinical Care and Aging 2005;13[3]:41-45)
Orthostatic and Postprandial Hypotension Assessment and Management Orthostatic and Postprandial Hypotension Assessment and Management Lewis A. Lipsitz, MD This article was adapted from a session at the 1999 American Geriatrics Society Annual Meeting. Indeed, among individuals with systolic blood pressure above 160, prevalence of orthostatic hypotension remains uniformly high regardless of age.3 This suggests that hypertension, rather than age, may be the principal factor underlying ...
Angiotensin Receptor Blocker Use for Hypertension Treatment in the Elderly Angiotensin Receptor Blocker Use for Hypertension Treatment in the Elderly Viseslav Drincic, MD, Sini Koshy, BS, and George Bakris, MD Angiotensin receptor blockers (ARBs) are a new class of drug that has entered the hypertension market within the last five years. Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure. Angiotensin II receptor ...
Recent Abstracts From Medical Literature for the Geriatric Practitioner Recent Abstracts From Medical Literature for the Geriatric Practitioner Risks of Untreated and Treated Isolated Systolic Hypertension in the Elderly: Meta-Analysis of Outcome Trials Meta-analysis of outcome trials in hypertension has not previously focused on isolated systolic hypertension, nor has it shown the treatment benefit of reducing diastolic blood pressure. ...
-------------------------------------------------------------------------------- Effect of Treating Isolated Systolic Hypertension on the Risk of Developing Various Types and Subtypes of Stroke The Systolic Hypertension in the Elderly Program (SHEP) confirmed that treating isolated systolic hypertension in older patients minimizes the incidence of total stroke, although whether all types of stroke are reduced was unknown. The present investigators tabulated stroke occurrence; type, subtype, ...
Evaluation and Management Services Evaluation and Management (E/M) Services were created by the American Medical Association in 1966 to standardize the approach to patient assessment and care. This code is used to bill for the evaluation and management of a patient who requires a detailed history, a detailed examination, and medical decision making of moderate complexity. This code is used to bill for the evaluation and management of a patient who requires a comprehensive history, a ...
Alzheimer?s disease (AD) is a bad thing. Nearly everyone would like a treatment that would cure or prevent AD. As of 2004, we do not have such a treatment available.
3. Heart Failure Society of America (HFSA) practice guidelines: HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction ? The effect of carvedilol on morbidity and mortality in patients with chronic heart failure.US Carvedilol Heart Failure Study Group. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure.